文献速递骨质疏松与代谢性骨病创伤骨科

50岁以上非严重外周骨折患者的椎体骨折评估(VFA)

Vertebral fracture assessment (VFA) in patients over 50 years of age with a non-severe peripheral fracture.
PubMed 文献 · Osteoporos Int · 2020-04-07

一项单中心横断面观察研究纳入114例50岁以上近期低创伤非严重外周骨折患者,系统VFA检出21%存在未知椎体骨折。VFA结果使35.3%已接受骨质疏松药物治疗者的管理发生改变,支持在该人群系统开展VFA。

要点

  • 50岁以上非严重外周骨折患者中,VFA检出21%存在一个以上未知椎体骨折。
  • VFA检出的30个椎体骨折中,1级占66.7%、2级占23.3%、3级占10%。
  • VFA结果使35.3%已用骨质疏松药物者的管理发生改变。

核心结论

  • 在50岁以上近期低创伤非严重外周骨折患者中,系统VFA有助于检出既往未知的椎体骨折并改变骨质疏松管理。

研究设计与样本

  • 359例符合条件患者中纳入114例,平均年龄65.6±8.4岁,女性占89.5%。
  • VFA由两名受训风湿科医生采用Genant半定量评估共识判读。

主要发现

  • 24例(21%)经VFA诊断一个或多个椎体骨折,共诊断30个椎体骨折。
  • 30个椎体骨折中,1级20个(66.7%)、2级7个(23.3%)、3级3个(10%)。
  • 24例有至少一个VFA椎体骨折的患者中,18例(66.7%)因VFA结果调整骨质疏松用药,6例(33.3%)无VFA结果也会用药,差异P<0.001。
  • 在DXA和VFA后接受骨质疏松药物的51例中,18例(35.3%)在获知VFA结果后管理发生改变。
  • VFA诊断的所有椎体骨折此前均未知;未发现年龄、T值或身高丢失的阈值以下不检出椎体骨折。

关键数值与推荐

  • 椎体骨折经VFA采用Genant半定量评估判读,按1、2、3级分类。
  • 24例有VFA椎体骨折患者中18例调整骨质疏松用药,包括16例启动药物和2例治疗强化。

临床怎么用

  • 对50岁以上近期低创伤非严重外周骨折患者,可考虑系统VFA以检出未知椎体骨折。
  • VFA结果可支持启动或强化骨质疏松药物治疗决策。

局限性

  • 本研究为单中心横断面观察性研究,359例符合条件者中仅114例(31.8%)纳入。
  • 未发现年龄、T值或身高丢失的阈值可提示无需VFA。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: The prevalence of unknown vertebral fractures evaluated by systematic vertebral fracture assessment (VFA) was 21% in patients over 50 years of age who suffered from a recent low-trauma non-severe peripheral fracture. The outcome of VFA resulted in changes in the management of osteoporosis. INTRODUCTION: The aim of this study was to evaluate the utility of VFA in detecting vertebral fractures (VFs) in patients over 50 years of age, who suffered from a recent low-trauma non-severe peripheral fracture. METHODS: This was an observational, single-center, cross-sectional study conducted in patients over 50 years of age, who presented a recent low-trauma non-severe peripheral fracture and were identified by the Fracture Liaison Service (FLS) of Amiens University Hospital between December 2017 and March 2019. VFA was interpreted by two trained rheumatologists providing a consensual reading using Genant semi-quantitative assessment. RESULTS: Of the 359 eligible patients, 114 patients (31.8%) were included (mean age 65.6 ± 8.4 years; 89.5% female). Twenty-four patients (21%) had one or more VF diagnosed by VFA. The total number of VF diagnosed by VFA was 30: 20 VF (66.7%) grade 1, 7 VF (23.3%) grade 2, and 3 VF (10%) grade 3. Among the 24 patients with at least one prevalent VF diagnosed by VFA, 18 patients had an osteoporosis medication adaptation after the VFA results (16 osteoporosis medication initiation and 2 treatment intensification), and 6 patients would have had an osteoporosis medication even without the VFA results (66.7% versus 33.3% respectively, p < 0.001). Of the 51 patients receiving an osteoporosis medication after DXA and VFA, 18 patients (35.3%) had a change in the management of osteoporosis after knowing the outcome of VFA. All the VFs diagnosed by VFA were unknown before. We did not evidence any threshold (age, T-score, height loss) below which no VF was detected. CONCLUSIONS: Our study demonstrates the usefulness of systematic VFA to detect prevalent VF in patients over 50 years of age who suffer from a recent non-severe peripheral fracture.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Aboudiab M, Grados F, Batteux B, et al. Vertebral fracture assessment (VFA) in patients over 50 years of age with a non-severe peripheral fracture. Osteoporos Int. 2020. PMID: 32266434. doi:10.1007/s00198-020-05400-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。